Search results
Novartis (NVS) to Buy MorphoSys & Add Late-Stage Oncology Drug
Zacks via Yahoo News· 5 months agoNovartis NVS announced that it will acquire Germany-based global biopharmaceutical company MorphoSys...
Novartis (NVS) to Undertake Job Cuts in Development Department
Zacks via Yahoo News· 3 months agoNovartis NVS is set to reduce its workforce by 680, per a report by Reuters. It will do so in its...
Top Research Reports for Novartis, Lowe's & Goldman Sachs
Zacks via Yahoo News· 2 years agoToday's Research Daily features new research reports on 12 major stocks, including Novartis AG...
Voyager (VYGR) Gains on Gene Therapy Deal With Novartis
Zacks via Yahoo News· 6 months agoVoyager (VYGR) enters into a capsid license agreement with Novartis for Huntington's disease and...
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
Zacks via Yahoo News· 3 months agoNovartis (NVS) announces encouraging data on Fabhalta from a phase III study for the treatment for...
Novartis (NVS) to Report Q1 Earnings: What to Expect?
Zacks via Yahoo News· 2 months agoNovartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2024 results on Apr 23....
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo News· 2 months agoSwiss pharma giant Novartis AG NVS reported better-than-expected results for the first quarter of...
Why Novartis (NVS) Might Surprise This Earnings Season
Zacks via Yahoo News· 12 months agoInvestors are always looking for stocks that are poised to beat at earnings season and Novartis AG...
Novartis (NVS) Gets CHMP Positive Opinion for Entresto Approval
Zacks via Yahoo News· 1 year agoNovartis NVS announced that its cardiovascular drug Entresto (sacubitril/valsartan) has received a...
Novartis (NVS) Stock Moves -0.58%: What You Should Know
Zacks via Yahoo News· 2 years agoIn the latest trading session, Novartis (NVS) closed at $75.57, marking a -0.58% move from the...